Cited by 966Amyotrophic Lateral Sclerosis ResearchHereditary Neurological DisordersAlzheimer's disease research and treatments

Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways

Open access
Cirulli, Elizabeth T., Lasseigne, Brittany N., Petrovski, Slavé, Sapp, Peter C., Dion, Patrick A., Leblond, Claire S., Couthouis, Julien, Lu, Yi-Fan +64 more·2015·Science

Abstract

New players in Lou Gehrig's disease: Amyotrophic lateral sclerosis (ALS), often referred to as “Lou Gehrig's disease,” is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. Cirulli et al. sequenced the expressed genes of nearly 3000 ALS patients and compared them with those of more than 6000 controls (see the Perspective by Singleton and Traynor). They identified several proteins that were linked to disease in patients. One such protein, TBK1, is implicated in innate immunity and autophagy and may represent a therapeutic target. Science , this issue p. 1436 ; see also p. 1422

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/science.aaa3650

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Genetic studies provide evidence that defects in autophagy predispose to amyotrophic lateral sclerosis.

    “genetic studies have provided evidence that defects in autophagy predispose to ALS (156, 157).”
  • Neuropathological analysis of CNS tissue from ALS patients with TBK1 mutations shows SQSTM1- and TARDBP-positive inclusions in motor neurons and glia, along with reduced TBK1 mRNA and protein, suggesting haploinsufficiency mechanisms.

    “Neuropathological analysis of CNS tissue from ALS patients with TBK1 mutations shows SQSTM1- and TARDBP-positive inclusions in motor neurons and glia [206,210,211], along with reduced TBK1 mRNA and protein, suggesting haploinsufficiency mechanisms [205,206].”
  • TBK1 mutations are responsible for ~1% of patients with familial or otherwise sporadic ALS.

    “Whole exome sequencing studies revealed that mutations in TBK1 are also responsible for ~1% of patients with familial or otherwise sporadic ALS [205,206].”
  • ALS-associated mutations in TBK1, OPTN, SQSTM1, and VCP all affect autophagy as well as microglial function and innate immunity.

    “ALS-associated mutations in TBK1, OPTN, SQSTM1, and VCP all affect autophagy as well as microglial function and innate immunity [192,205,206,441–443].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Cirulli, E. T., Lasseigne, B. N., Petrovski, S., Sapp, P. C., Dion, P. A., Leblond, C. S., Couthouis, J., Lu, Y.-F., Wang, Q., Krueger, B. J., Ren, Z., Keebler, J., Han, Y., Levy, S. E., Boone, B. E., Wimbish, J. R., Waite, L. L., Jones, A. L., Carulli, J. P., Day-Williams, A. G., Staropoli, J. F., Xin, W. W., Chesi, A., Raphael, A. R., McKenna-Yasek, D., Cady, J., Vianney de Jong, J. M. B., Kenna, K. P., Smith, B. N., Topp, S., Miller, J., Gkazi, A., FALS Sequencing Consortium, Al-Chalabi, A., van den Berg, L. H., Veldink, J., Silani, V., Ticozzi, N., Shaw, C. E., Baloh, R. H., Appel, S., Simpson, E., Lagier-Tourenne, C., Pulst, S. M., Gibson, S., Trojanowski, J. Q., Elman, L., McCluskey, L., Grossman, M., Shneider, N. A., Chung, W. K., Ravits, J. M., Glass, J. D., Sims, K. B., Van Deerlin, V. M., Maniatis, T., Hayes, S. D., Ordureau, A., Swarup, S., Landers, J., Baas, F., Allen, A. S., Bedlack, R. S., Harper, J. W., Gitler, A. D., Rouleau, G. A., Brown, R., Harms, M. B., Cooper, G. M., Harris, T., Myers, R. M., & Goldstein, D. B.
Affiliations
  • Duke University (US)
  • HudsonAlpha Institute for Biotechnology (US)
  • Columbia University (US)
  • University of Massachusetts Chan Medical School (US)
  • Montreal Neurological Institute and Hospital (CA)
  • Stanford Medicine (US)
  • Institute for Genomic Medicine, Columbia University, New York, NY 10032, USA.
  • Duke University School of Medicine, Durham, NC 27708, USA.
  • Biogen (United States) (US)
  • Biogen Idec, Cambridge, MA 02142, USA.
  • Harvard University (US)
  • Washington University in St. Louis (US)
  • Department of Genome Analysis, Academic Medical Center, Meibergdreef 9, 1105AZ Amsterdam, Netherlands.
  • Trinity College Dublin (IE)
  • King's College London (GB)
  • Department of Basic and Clinical Neuroscience, King’s College London, Institute of Psychiatry, Psychology and Neuroscience, London SE5 8AF, UK.
  • Department of Neurology, Brain Center Rudolf Magnus, University Medical Centre Utrecht, 3508 GA Utrecht, Netherlands.
  • University Medical Center Utrecht (NL)
  • University of Milan (IT)
  • Cedars-Sinai Medical Center (US)
  • Houston Methodist (US)
  • Ludwig Institute for Cancer Research and Department of Neurosciences, University of California, San Diego, La Jolla, CA 92093, USA.
  • University of Utah (US)
  • University of Pennsylvania (US)
  • Columbia University Irving Medical Center (US)
  • University of California San Diego (US)
  • Emory University (US)
  • Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Amsterdam UMC Location University of Amsterdam (NL)
  • Durham VA Medical Center (US)
Corresponding author
  • Cirulli, Elizabeth T.
  • Lasseigne, Brittany N.
  • Harris, Tim
  • Myers, Richard M.
  • Goldstein, David B.
Venue
Science
Published
2015-03-27
Volume
347
Issue
6229
Pages
1436-1441
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W2061194981
Cited by
966
References
63
Citations by year
2026: 34 · 2025: 53 · 2024: 66 · 2023: 62 · 2022: 75 · 2021: 82 · 2020: 107 · 2019: 94 · 2018: 110 · 2017: 107 · 2016: 114 · 2015: 62
FWCI
92.36
Type
journal article
Language
en
Open access
Locations
  • Science (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • ePrints Soton (University of Southampton) (acceptedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
  • eScholarship (California Digital Library) (submittedVersion)
  • Research Portal (King's College London) (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion, other-oa)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
  • Research Portal (Queen's University Belfast) (submittedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion)
Funders
  • Wellcome Trust (089701)
  • National Institute for Health and Care Research (NF-SI-0512-10082)
  • Motor Neurone Disease Association (TURNER/JAN13/944-795)
  • National Institutes of Health (5ul1tr001067-05, TL1TR001066)
  • Medical Research Council (MR/L021803/1, MC_G1000733, MR/L016397/1, MR/K01014X/1, MR/L501529/1)
  • National Institute on Aging (P01AG017586, P50AG025688, P01AG032953)
  • National Institute of General Medical Sciences (T32GM007754)
  • National Institute of Neurological Disorders and Stroke (R01NS073873, K08NS075094, R37NS083524, R37NS033123)
  • National Center for Advancing Translational Sciences (UL1-TR001067)
Topics
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
amyotrophic lateral sclerosis, genetic risk factors, TBK1, optineurin, p62, autophagy, innate immunity, susceptibility genes, therapeutic target
MeSH terms
Sequestosome-1 Protein, Adolescent, Adult, Aged, Aged, 80 and over, Amyotrophic Lateral Sclerosis, Autophagy, Female, Genes, Humans, Male, Middle Aged, Protein Binding, Risk, Protein Serine-Threonine Kinases, Sequence Analysis, DNA, Cell Cycle Proteins, Genetic Predisposition to Disease, Membrane Transport Proteins, Transcription Factor TFIIIA, Adaptor Proteins, Signal Transducing, Young Adult, Genetic Association Studies, Exome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review